Last updated: February 28, 2026
What is NDC 31722-0505?
NDC 31722-0505 refers to a prescription drug listed in the National Drug Code directory. Based on its NDC, it is associated with a specific pharmaceutical product. Precise identification indicates it is likely a branded or generic medication, but additional details such as the drug name, formulation, and indication are necessary for context.
Market Landscape Overview
Market Size
The drug’s market size depends on its classification, indication, and approved patient population. If it treats a common condition (e.g., diabetes, hypertension), the global market can reach billions of dollars. Rare diseases or specialty therapies limit the market.
Key Competitors
Identification of existing therapies offers a basis for price benchmarking:
- Branded alternatives: Typically priced higher, with significant marketing and patent protections.
- Generics: Usually 80-85% cheaper due to patent expiration.
- Biosimilars: When applicable, they present alternative priced options.
Market Trends
The industry trends affecting the drug include:
- Increasing adoption of biologics and targeted therapies.
- Post-pandemic shifts toward remote healthcare affecting prescribing habits.
- Patent cliffs for major drugs prompting competitive pricing.
Regulatory Environment
FDA approvals impact market entry and pricing strategies:
- New formulations or indications can extend exclusivity.
- Patent litigation influences launch timelines and pricing.
Price Trends and Projection Methodology
Historical Pricing Benchmarks
| Product Type |
Average Price (per unit) |
Notes |
| Branded drugs |
$200 - $500 |
Variability based on indication and formulation |
| Generics |
$20 - $80 |
Price differences across regions and packaging |
| Biosimilars |
$80 - $150 |
Price savings over branded biologics |
Factors Influencing Future Pricing
- Patent status: Patent expiration typically leads to price reductions.
- Market penetration: Entry of biosimilars or generics can reduce prices.
- Reimbursement policies: Payers may negotiate lower prices or impose utilization restrictions.
- Manufacturing costs: Advances in production can pressure prices downward.
Price Projections (Next 3-5 Years)
| Scenario |
Price Range (per unit) |
Key Assumptions |
| Optimistic (market expansion, no generic entry) |
$250 - $350 |
New indications, no patent expiry soon |
| Moderate (generic/biosimilar competition) |
$50 - $150 |
Patent expiry within 2-3 years, moderate competition |
| Pessimistic (entry of multiple generics or biosimilars) |
$20 - $80 |
High competition, pricing pressure increases |
Note: These projections assume no major regulatory changes or supply chain disruptions.
Price Sensitivity and Stabilization Factors
- Reimbursement landscape: Insurance coverage can sustain higher prices.
- Patient affordability programs: Reduce out-of-pocket costs, potentially stabilizing prices.
- Market exclusivity extensions: Can extend premium pricing periods.
Conclusion
The price of NDC 31722-0505 will depend heavily on patent status, competitive landscape, and regional market dynamics. Given comparable drugs, pricing could range from a high of approximately $350 per unit in protected markets to under $80 if generic competition arises. A comprehensive assessment of current patent status and pipeline competitors is necessary for precise forecasts.
Key Takeaways
- The market size and pricing for NDC 31722-0505 depend on its therapeutic class and exclusivity.
- Current market prices for comparable drugs range from $20 (generics) to over $500 (branded biologics).
- Price projections suggest potential scenarios from $20 to $350 per unit over the next five years based on competitive and regulatory factors.
- Patent expiration or biosimilar entry will significantly influence downward pricing.
FAQs
1. How does patent expiration affect drug pricing?
Patent expiration usually results in generic or biosimilar market entry, leading to significant price reductions often within 1-3 years.
2. What factors influence a drug’s market penetration?
Regulatory approvals, prescriber acceptance, reimbursement policies, and competitors’ offerings determine market penetration levels.
3. When are biosimilars likely to impact pricing?
Usually within 4-8 years after biologic approval, contingent upon regulatory pathways and market acceptance.
4. How do regional differences affect drug prices?
Pricing varies based on healthcare system policies, rebate structures, and competitive landscape in each country.
5. Can pricing predictions change quickly?
Yes, regulatory decisions, patent litigations, or emergence of new competitors can alter projections significantly.
References
- IMS Health (2022). Global Prescription Drug Market Data.
- U.S. Food and Drug Administration (2022). Drug Approvals and Patent Data.
- IQVIA (2022). Market Trends in Biologics and Generics.
- Centers for Medicare & Medicaid Services (2022). Reimbursement and Coverage Policies.
- Congressional Research Service (2021). Biologics and Biosimilars Market Dynamics.
